Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203624
Company: RISING
Company: RISING
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| ACETYLCYSTEINE | ACETYLCYSTEINE | 6GM/30ML (200MG/ML) | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 06/19/2015 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 09/04/2020 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
||
| 08/21/2019 | SUPPL-3 | Labeling-Package Insert |
Label is not available on this site. |
||
| 08/21/2019 | SUPPL-2 | Labeling-Package Insert |
Label is not available on this site. |